Lifevantage Corp (LFVN) Form 8-K Material Events
Lifevantage Corp (LFVN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LFVN
CIK: 849146
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 6/30/2023 12:00:00 AM
Lead Engagement PartnerWesley Yeomans
Audit LocationSalt Lake City, Utah, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-09 | 2026-10-07 | 4 | 0001193125-26-419109 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-07 | 4 | 0001193125-26-419094 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-07 | 4 | 0001193125-26-419076 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | 4 | 0001193125-26-414130 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | 4 | 0001193125-26-414128 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-09-29 | 8-K | 0001193125-26-414122 | View SEC Doc Filr Page |
| ARS | 2026-09-18 | 2026-06-30 | ARS | 0001193125-26-395555 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-18 | — | DEFA14A | 0001193125-26-395535 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-18 | 2026-11-05 | DEF 14A | 0001193125-26-395513 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-394331 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390924 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390923 | View SEC Doc Filr Page |
| 8-K | 2026-08-27 | 2026-08-27 | 8-K | 0001193125-26-371265 | View SEC Doc Filr Page |
| 10-K | 2026-08-27 | 2026-06-30 | 10-K | 0001193125-26-371257 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001037389-26-000053 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 | 0001193125-26-342696 | View SEC Doc Filr Page |
| 3 | 2026-08-10 | 2026-08-05 | 3 | 0001193125-26-342686 | View SEC Doc Filr Page |
| S-8 | 2026-08-03 | — | S-8 | 0001193125-26-330549 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-07-31 | 8-K | 0001193125-26-330531 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0002012383-26-002814 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296262 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296260 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296258 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-06 | — | SCHEDULE 13G/A Filing | 0001420506-26-001196 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 | 0001193125-26-274127 | View SEC Doc Filr Page |